drugset / Trial / NCT01443858
Meclizine as a Potential Smoking Cessation Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-12
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meclizine | Small molecule | 25 mg | — |
| Subject | Meclizine | Small molecule | 50 mg | — |
| Background | Nicotine | Unknown | 21 mg | Topical |
Indications
No indication recorded.